3559 results for «278»
3559 results
Intracoronary imaging to guide management in ACS
16 May 2024 – From EuroPCR 2024
This session focuses on the role of intracoronary imaging, specifically IVUS and OCT, in the management of Acute Coronary Syndrome (ACS). Participants will learn when intracoronary imaging can facilitate diagnosis and guide PCI, as well as discuss image interpretation in the setting of ACS.
Devices in pulmonary embolism - Why you should be interested!
15 May 2024 – From EuroPCR 2024
This session provides a comprehensive overview of device-based pulmonary embolism treatment. Experts will discuss the clinical problem of pulmonary embolism, the importance of forming a dedicated team, and the available devices and their characteristics. The session will also feature case-based discussions on the use of catheter-directed...
Management of patient with coronary artery disease and left ventricle dysfunction
15 May 2024 – From EuroPCR 2024
This session focuses on the management of patients with stable coronary artery disease and left ventricular dysfunction. Experts will discuss the role of mechanical circulatory support devices in these patients, as well as the diagnosis and treatment of microvascular angina, which can be a challenging complication...
Nightmare cases
15 May 2024 – From EuroPCR 2024
Antiplatelet de-escalation after complex PCI: when and how?
15 May 2024 – From EuroPCR 2024
Acute and chronic right ventricular failure: focus on the weak link
16 May 2024 – From EuroPCR 2024
This session discusses new diagnostic and therapeutic aspects of shock due to right ventricular infarction, explores why and how the failing right ventricle contributes to worsening heart failure, and examines device-based treatment opportunities for chronic right ventricular and tricuspid valve failure, including repair vs replacement. It...
PCI of bifurcation lesions: management of complications - Part 1
16 May 2024 – From EuroPCR 2024
Explore strategies for managing complex PCI of bifurcation lesions through case discussions. From stent deformation and delicate diagonal wiring to wire fracture with snare failure, decoiled coronary guidewires, misplaced stents, spontaneous coronary artery dissection, and late tamponade after PCI, this session covers how to effectively respond...
From machine learning to redo-TAVR: Pioneering abstracts unveiled
16 May 2024 – From EuroPCR 2024
This session features selected abstract submissions from EuroPCR 2024, showcasing the latest innovations and research in interventional cardiology. The presenters will have the opportunity to share their work and receive feedback from the audience, fostering collaboration and the exchange of ideas within the interventional cardiology community.
First results of randomised trials on advanced plaque modification techniques and intracoronary imaging
16 May 2024 – From EuroPCR 2024
This session presents the first results of randomized trials investigating the use of advanced plaque modification techniques, such as rotational atherectomy, lithotripsy, and laser atherectomy, as well as the role of intracoronary imaging (OCT and IVUS) in guiding percutaneous coronary intervention (PCI). The session aims to...
Mitral and tricuspid hotline
16 May 2024 – From EuroPCR 2024
This session provides updates on the latest developments in transcatheter mitral and tricuspid valve interventions. Key topics include one-year outcomes of the MiCLASP study on transcatheter mitral repair, the impact of residual mitral and tricuspid regurgitation after transcatheter repair, and the early feasibility of the AltaValve...
New evidence on TAVI from PCR Companions
17 May 2024 – From EuroPCR 2024
This session features selected EuroPCR 2024 abstract submissions presenting the latest evidence on TAVI. Topics include device success in valve-in-valve TAVI, next-day discharge after TAVI, comparative network meta-analysis of PCI strategies in TAVI patients, factors associated with thrombosis treatment response, and outcomes of a novel balloon-expandable...
Imaging and physiology guided PCI
17 May 2024 – From EuroPCR 2024
This session features selected EuroPCR 2024 clinical case submissions showcasing the use of imaging and physiology guidance during PCI. Cases cover topics such as managing cardiac arrest during PCI, virtual reality-guided PCI, low-contrast PCI in multivessel disease, and the comprehensive assessment of obstructive and non-obstructive coronary...
Management of PCI complications - Part 1
16 May 2024 – From EuroPCR 2024
This session comprises a series of selected EuroPCR 2024 Clinical Case submissions, focusing on the management of various PCI complications. Participants will explore cases involving coronary physiology challenges, iatrogenic compressive coronary intramural hematoma, misbehaving stents, catheter-induced dissections, and device malfunctions, along with the corresponding bailout techniques...
Long-term results and durability of the CoreValve transcatheter aortic bioprosthesis: outcomes beyond five years
28 Mar 2019
A study to determine the long-term outcomes of high-risk patients who underwent transcatheter aortic valve implantation with the third-generation CoreValve device, according to the 2017 EAPCI/ESC/EACTS definition of valve durability.
Authors :
Impella percutaneous ventricular assist device malrotation in social media: a call to action
20 Apr 2023
The data from this study suggest that, from a SoMe perspective, correct Impella orientation is often overlooked, and that Impella malrotation is a common issue in real-world clinical practice, potentially associated with relevant complications.
Author
Author
Author
Author
Author
30 years of primary PCI – a tale of perseverance
16 May 2023
Over the last 30 years, primary PCI (pPCI) has evolved from an experimental ‘rescue’ intervention to an essential routine procedure – performed daily in cathlabs around the world – which is responsible for saving millions of lives. However, its path to success was far from smooth.
BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial
07 Nov 2022
Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.
This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...
Author
The impact of COVID-19 pandemic on interventional cardiologists in training
23 Oct 2020
In collaboration with EuroIntervention Journal
The authors decided to create a survey tailored for ICTs in order to assess the changes in their training. Capturing the essence of the responses may help to identify the most appropriate strategies to provide the highest standards and skills achievements in COVID-19...
Intravascular ultrasound-guided versus angiography-guided percutaneous coronary intervention in acute coronary syndromes: The multicenter, randomized, blinded, IVUS-ACS Trial
09 Apr 2024
Marco Spagnolo and Daniele Giacoppo report the main results of the IVUS-ACS trial presented by Shao-Liang Chen, from the Nanjing First Hospital, Nanjing Medical University, Nanjing, in a Featured Clinical Research session at ACC.24 in Atlanta and simultaneously published in The Lancet.(1)
Author
Author
